196 related articles for article (PubMed ID: 24192311)
21. Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.
Mane A; Sahasrabuddhe VV; Nirmalkar A; Risbud AR; Sahay S; Bhosale RA; Vermund SH; Mehendale SM
J Clin Virol; 2017 Mar; 88():26-32. PubMed ID: 28152432
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria.
Kennedy NT; Ikechukwu D; Goddy B
Pan Afr Med J; 2016; 23():85. PubMed ID: 27222684
[TBL] [Abstract][Full Text] [Related]
23. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.
Garbuglia AR; Piselli P; Lapa D; Sias C; Del Nonno F; Baiocchini A; Cimaglia C; Agresta A; Capobianchi MR
J Clin Virol; 2012 Jun; 54(2):141-6. PubMed ID: 22437054
[TBL] [Abstract][Full Text] [Related]
24. High-risk human papillomaviruses distribution in Romanian women with negative cytology.
Plesa A; Socolov D; Huica I; Botezatu A; Iancu IV; Ungureanu C; Teleman S; Albulescu A; Fudulu A; Anton G
J Infect Dev Ctries; 2019 Apr; 13(4):326-333. PubMed ID: 32045377
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Human Papillomavirus, Human Immunodeficiency Virus, and Other Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo: A National Cross-sectional Survey.
Ferré VM; Gbeasor-Komlanvi FA; Collin G; Dagnra AC; Le Hingrat Q; Jaquet A; Salou M; Descamps D; Charpentier C; Ekouevi DK
Clin Infect Dis; 2019 Aug; 69(6):1019-1026. PubMed ID: 30520971
[TBL] [Abstract][Full Text] [Related]
26. Human Papillomavirus Prevalence Among American Indian Women of the Great Plains.
Lee NR; Winer RL; Cherne S; Noonan CJ; Nelson L; Gonzales AA; Umans JG; Buchwald D;
J Infect Dis; 2019 Feb; 219(6):908-915. PubMed ID: 30321371
[TBL] [Abstract][Full Text] [Related]
27. Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.
Namujju PB; Waterboer T; Banura C; Muwonge R; Mbidde EK; Byaruhanga R; Muwanga M; Surcel HM; Pawlita M; Lehtinen M
J Gen Virol; 2011 Dec; 92(Pt 12):2776-2783. PubMed ID: 21832008
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status.
Olesen TB; Iftner T; Mwaiselage J; Kahesa C; Rasch V; Ngoma T; Munk C; Kjaer SK
Sex Transm Dis; 2013 Jul; 40(7):592-8. PubMed ID: 23965778
[TBL] [Abstract][Full Text] [Related]
29. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women.
Ezechi OC; Ostergren PO; Nwaokorie FO; Ujah IA; Odberg Pettersson K
Virol J; 2014 Jan; 11():5. PubMed ID: 24433568
[TBL] [Abstract][Full Text] [Related]
30. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria.
Okunade KS; Nwogu CM; Oluwole AA; Anorlu RI
Pan Afr Med J; 2017; 28():227. PubMed ID: 29629013
[TBL] [Abstract][Full Text] [Related]
34. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.
Couture MC; Page K; Stein ES; Sansothy N; Sichan K; Kaldor J; Evans JL; Maher L; Palefsky J
BMC Infect Dis; 2012 Jul; 12():166. PubMed ID: 22839728
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.
Ortiz AP; Tamayo V; Scorsone A; Soto-Salgado M; Febo I; Piovanetti P; Venegas-Ríos HL; Yamamura Y; Zorrilla C
Papillomavirus Res; 2017 Dec; 4():39-44. PubMed ID: 29179868
[TBL] [Abstract][Full Text] [Related]
36. hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
Fitzpatrick MB; Dube Mandishora RS; Katzenstein DA; McCarty K; Weber J; Sahoo MK; Manasa J; Chirenje ZM; Pinsky BA
Int J Infect Dis; 2019 May; 82():21-29. PubMed ID: 30807869
[TBL] [Abstract][Full Text] [Related]
37. Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.
Menezes LJ; Pokharel U; Sudenga SL; Botha MH; Zeier M; Abrahamsen ME; Glashoff RH; Engelbrecht S; Schim van der Loeff MF; van der Laan LE; Kipping S; Taylor D; Giuliano AR
Sex Transm Infect; 2018 Feb; 94(1):55-61. PubMed ID: 28490581
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus correlates of high grade cervical dysplasia among HIV-Infected women at a major treatment centre in Nigeria: a cross-sectional study.
Yakub MM; Fowotade A; Anaedobe CG; Manga MM; Bakare RA; Abimiku BA
Pan Afr Med J; 2019; 33():125. PubMed ID: 31558924
[TBL] [Abstract][Full Text] [Related]
39. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada.
Ogilvie GS; Cook DA; Taylor DL; Rank C; Kan L; Yu A; Mei W; van Niekerk DJ; Coldman AJ; Krajden M
Vaccine; 2013 Feb; 31(7):1129-33. PubMed ID: 23273510
[TBL] [Abstract][Full Text] [Related]
40. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix.
Stuebs FA; Gass P; Dietl AK; Schulmeyer CE; Adler W; Geppert C; Hartmann A; Knöll A; Beckmann MW; Koch MC
Arch Gynecol Obstet; 2021 Sep; 304(3):751-758. PubMed ID: 33538863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
